Biocryst Pharmaceuticals Inc (BCRX): Billionaire David E. Shaw’s Fund Increases Stake

Page 2 of 6 – SEC Filing

CUSIP No. 09058V103

1.

Names of Reporting Persons

I.R.S. Identification Nos. of above persons (entities only)

D. E. Shaw & Co., L.P.

13-3695715

2. Check the Appropriate Box if a Member of a Group (See Instructions)
(a) [     ]

(b)

[     ]
3.

SEC Use Only

4.

Citizenship or Place of Organization

Delaware

Number of

Shares

Beneficially

Owned by

Each

Reporting

Person With

5.

Sole Voting Power

-0-

6.

Shared Voting Power

3,698,639

7.

Sole Dispositive Power

-0-

8.

Shared Dispositive Power

3,740,239

9.

Aggregate Amount Beneficially Owned by Each Reporting Person

3,740,239

10.

Check if the Aggregate Amount in Row (9) Excludes Certain
Shares (See Instructions) [     ]

11.

Percent of Class Represented by Amount in Row (9)

5.1%

12.

Type of Reporting Person (See Instructions)

IA, PN

Follow Biocryst Pharmaceuticals Inc (NASDAQ:BCRX)